Literature DB >> 11796390

Early dissemination of CTX-M-derived enzymes in South America.

Marcela Radice, Pablo Power, Jose Di Conza, Gabriel Gutkind.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11796390      PMCID： PMC127077          DOI： 10.1128/AAC.46.2.602-604.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  22 in total

1.  A novel plasmid-mediated extended-spectrum beta-lactamase not derived from TEM- or SHV-type enzymes.

Authors:  H Bernard; C Tancrede; V Livrelli; A Morand; M Barthelemy; R Labia
Journal:  J Antimicrob Chemother       Date:  1992-05       Impact factor: 5.790

2.  Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum beta-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca.

Authors:  M Barthélémy; J Péduzzi; H Bernard; C Tancrède; R Labia
Journal:  Biochim Biophys Acta       Date:  1992-07-13

3.  A new plasmidic cefotaximase from patients infected with Salmonella typhimurium.

Authors:  A Bauernfeind; J M Casellas; M Goldberg; M Holley; R Jungwirth; P Mangold; T Röhnisch; S Schweighart; R Wilhelm
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

4.  A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil.

Authors:  R Bonnet; J L Sampaio; R Labia; C De Champs; D Sirot; C Chanal; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

5.  Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital.

Authors:  A Pałucha; B Mikiewicz; W Hryniewicz; M Gniadkowski
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

6.  Cefotaxime-hydrolysing beta lactamases in Morganella morganii.

Authors:  P Power; M Radice; C Barberis; C de Mier; M Mollerach; M Maltagliatti; C Vay; A Famiglietti; G Gutkind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-10       Impact factor: 3.267

7.  Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.

Authors:  R Bonnet; C Dutour; J L Sampaio; C Chanal; D Sirot; R Labia; C De Champs; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

8.  Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins.

Authors:  Y Matsumoto; F Ikeda; T Kamimura; Y Yokota; Y Mine
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

9.  A new plasmidic cefotaximase in a clinical isolate of Escherichia coli.

Authors:  A Bauernfeind; H Grimm; S Schweighart
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

10.  Third-generation cephalosporin resistance in Shigella sonnei, Argentina.

Authors:  M Radice; C Gonzéález; P Power; M C Vidal; G Gutkind
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883
View more
  26 in total

Review 1.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

Review 2.  ISCR elements: novel gene-capturing systems of the 21st century?

Authors:  Mark A Toleman; Peter M Bennett; Timothy R Walsh
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

3.  Detection of CTX-M-1, CTX-M-15, and CTX-M-2 in clinical isolates of Enterobacteriaceae in Bogota, Colombia.

Authors:  Emilia María Valenzuela de Silva; José Ramón Mantilla Anaya; María Teresa Reguero Reza; Elsa Beatriz González Mejía; Ingrid Yamile Pulido Manrique; Iván Darío Llerena; Daniel Velandia
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  Biochemical characterization of PER-2 and genetic environment of blaPER-2.

Authors:  Pablo Power; José Di Conza; María Margarita Rodríguez; Bárbara Ghiglione; Juan A Ayala; José María Casellas; Marcela Radice; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

5.  PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

6.  Changing epidemiology of extended-spectrum β-lactamases in Argentina: emergence of CTX-M-15.

Authors:  S Sennati; G Santella; J Di Conza; L Pallecchi; M Pino; B Ghiglione; G M Rossolini; M Radice; G Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

7.  Emergence of extended-spectrum-β-lactamase CTX-M-2-producing Salmonella enterica serovars Schwarzengrund and Agona in poultry farms.

Authors:  Ketrin C Silva; Lívia C Fontes; Andrea M Moreno; Claudete S Astolfi-Ferreira; Antonio J P Ferreira; Nilton Lincopan
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

8.  Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital.

Authors:  Véronique Leflon-Guibout; Cécile Jurand; Stéphane Bonacorsi; Florence Espinasse; Marie Claude Guelfi; Françoise Duportail; Beate Heym; Edouard Bingen; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals.

Authors:  M Quinteros; M Radice; N Gardella; M M Rodriguez; N Costa; D Korbenfeld; E Couto; G Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

10.  Study of CTX-M Type of Extended Spectrum β-Lactamase among Nosocomial Isolates of Escherichia coli and Klebsiella pneumoniae in South India.

Authors:  R Mohamudha Parveen; Subha Manivannan; B N Harish; S C Parija
Journal:  Indian J Microbiol       Date:  2011-01-25       Impact factor: 2.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.